PDUFA V's Next Stop Is An Oct. 24 Public Hearing; FDA Hopes Final Stop Is 129 New FTEs
This article was originally published in The Pink Sheet Daily
Executive Summary
The proposed user fee deal will get public input one last time before going to Congress.
You may also be interested in...
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
PDUFA V Commitment Letter Front-Loads Guidance, Meeting Milestones
It may not feel like it to exhausted user fee negotiators, but the release of FDA’s draft commitment letter for PDUFA V signals the start of more long campaigns for the agency and pharmaceutical companies.